Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

98.46
+3.663.86%
Post-market: 99.290.8295+0.84%19:49 EDT
Volume:3.79M
Turnover:376.73M
Market Cap:6.16B
PE:-23.68
High:104.00
Open:95.41
Low:93.95
Close:94.80
52wk High:104.00
52wk Low:10.94
Shares:62.58M
Float Shares:39.01M
Volume Ratio:0.36
T/O Rate:9.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:100.85
PE(LYR):-22.78

Loading ...

OverviewCompanyNewsFilings

Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)

TIPRANKS
·
5 hours ago

Movement Alert｜Kodiak Sciences Inc. Rises 6.9% in Regular Trading, Major Shareholder Baker Brothers Adds Over 350,000 Shares

Market Focus
·
Yesterday

Form 4 | Kodiak Sciences directors and 10% owners Felix Baker and Julian Baker, via funds, purchased ~359,000 common shares (P).

Filings Track
·
Yesterday

Kodiak Sciences Inc. Director Felix J. Baker purchased 227,671 shares.

Filings Track
·
Yesterday

Kodiak Sciences Inc. Director Felix J. Baker acquired 639,386 shares.

Filings Track
·
Yesterday

Baker Bros. Advisors Buys $32.31 Million of Kodiak Sciences Common Shares

Reuters
·
Yesterday

Movement Alert｜Kodiak Sciences Inc. Rises 6.48% in Regular Trading, Phase 3 Clinical Success Continues to Lift Shares

Market Focus
·
Sep 30

Kodiak Sciences Inc. : JP Morgan Raises Target Price to $124 from $69

THOMSON REUTERS
·
Sep 29

Movement Alert｜Kodiak Sciences Inc. Falls 5.21% in Regular Trading, Pullback After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

Movement Alert｜Kodiak Sciences Inc. Falls 5.36% in Pre-Market Trading, Profit-Taking After 172% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

Movement Alert｜Kodiak Sciences Inc. Falls 7.83% Overnight, Retreating After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

NASD Most Active Issues

Dow Jones
·
Sep 29

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Reuters
·
Sep 29

Kodiak Sciences price target raised to $112 from $56 at Jefferies

TIPRANKS
·
Sep 29

Kodiak Sciences Price Target Raised to $96.00/Share from $58.00 by HC Wainwright & Co.

Dow Jones
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

TIPRANKS
·
Sep 29

Kodiak Sciences Inc. : H.c. Wainwright Raises Target Price to $96 from $58

THOMSON REUTERS
·
Sep 28

Top Midday Stories: MongoDB CEO Leaves to Lead Meta Enterprise Platform; Nvidia Ups Buyback Program by $150 Billion

MT Newswires Live
·
Sep 28

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28
More